STRING: 39946.BGIOSGA014428-PA
OSL Antibody is a research antibody developed against the OSL protein from Oryza sativa subsp. indica (rice). When selecting this antibody for research applications, it's important to understand that the antibody specifically targets the A2XX39 protein according to Uniprot designation. This antibody should be distinguished from the unrelated OncoSil Medical (OSL) which is a medical device company working on pancreatic cancer treatments . The antibody is available in both concentrated (0.1ml) and diluted (2ml) formats suitable for various experimental applications .
Methodologically, researchers should validate antibody specificity before experimental use through:
Western blot analysis with positive and negative controls
Peptide competition assays
Comparison with other validated antibodies targeting the same protein
Testing against OSL-deficient samples when available
When selecting between OSL Antibody and other rice protein antibodies such as OSL2 Antibody (CSB-PA712218XA01OFG, targeting Q7XN11 protein), researchers should consider several factors that affect experimental design and interpretation:
Sequence homology - OSL shares varying degrees of homology with other rice proteins, which may affect cross-reactivity profiles
Isoform specificity - Determine whether the antibody recognizes specific isoforms or all variants of the protein
Species specificity - OSL Antibody is optimized for Oryza sativa subsp. indica, while many other rice antibodies target japonica subspecies proteins
From a methodological perspective, researchers should:
Perform sequence alignment analysis before antibody selection
Include appropriate controls to assess potential cross-reactivity
Consider using multiple antibodies targeting different epitopes for confirmation
For maximum retention of antibody functionality:
Long-term storage: Store in aliquots at -20°C to avoid repeated freeze-thaw cycles
Working dilutions: Maintain at 4°C and use within 1-2 weeks
Stabilization: Consider adding protein stabilizers such as BSA (0.1-1%) or glycerol (25-50%)
Transportation: Use ice packs or dry ice depending on duration
Contamination prevention: Use sterile technique when handling
Researchers should implement a quality control system to track antibody performance across experiments, noting any batch-to-batch variations that may influence experimental outcomes or reproducibility.
Rigorous experimental design requires appropriate controls:
Positive controls:
Protein extracts from Oryza sativa subsp. indica with confirmed OSL expression
Recombinant OSL protein
Overexpression systems
Negative controls:
OSL knockout/knockdown samples when available
Secondary antibody-only controls
Isotype control antibodies
Pre-immune serum
Peptide competition assays
Samples from unrelated plant species
Loading/normalization controls:
Housekeeping proteins (actin, tubulin)
Total protein staining methods (Ponceau S, Coomassie)
When performing advanced applications such as co-immunoprecipitation, additional controls become necessary to account for non-specific binding to beads or other reagents.
OSL Antibody can provide valuable insights into rice stress response mechanisms through multiple experimental approaches:
Protein expression analysis:
Quantitative Western blotting to measure OSL protein levels under various stressors (drought, salinity, pathogens)
Time-course experiments to capture dynamic responses
Tissue-specific expression patterns using immunohistochemistry
Protein interaction studies:
Co-immunoprecipitation to identify stress-induced protein complexes
Proximity ligation assays to visualize in situ protein interactions
Pull-down assays to validate direct binding partners
Post-translational modification analysis:
Combination with phospho-specific detection methods
Analysis of OSL stability under stress conditions
Subcellular localization changes during stress response
Experimental design should include appropriate physiological measurements and molecular markers of stress to correlate OSL dynamics with established stress response pathways. This multifaceted approach allows researchers to place OSL function within broader stress response networks.
Understanding cross-reactivity is essential for accurate data interpretation:
Species cross-reactivity:
Higher specificity for Oryza sativa subsp. indica compared to japonica varieties
Potential cross-reactivity with closely related Poaceae family members
Limited or no reactivity with dicot species
Protein cross-reactivity:
May recognize highly conserved domains in related proteins
Potential recognition of processed forms or degradation products
Testing methodology for cross-reactivity:
Sequence alignment analysis to predict potential cross-reactivity
Western blotting against protein extracts from multiple species
Immunoprecipitation followed by mass spectrometry identification
Epitope mapping to determine recognition sites
Cross-reactivity patterns should be systematically documented to establish the antibody's limitations and applications across different experimental systems.
Post-translational modifications (PTMs) can significantly alter antibody-epitope interactions:
Phosphorylation effects:
If the epitope contains phosphorylation sites, modification may enhance or inhibit antibody binding
Phosphorylation near the epitope may cause conformational changes affecting recognition
Other PTMs potentially affecting binding:
Glycosylation
Ubiquitination
Acetylation
Methylation
Methodological approaches:
Compare detection in samples treated with or without phosphatases
Use Phos-tag™ SDS-PAGE to separate phosphorylated forms
Combine with phospho-specific antibodies in parallel experiments
Apply mass spectrometry to identify specific PTM sites
When studying stress responses or signaling pathways, researchers should be particularly aware of potential PTM-induced changes in antibody recognition.
For investigating protein complexes and interaction networks:
Co-immunoprecipitation (Co-IP):
Use OSL Antibody to pull down protein complexes
Analyze by Western blot or mass spectrometry
Compare interaction profiles under different conditions
Proximity-dependent labeling:
Combine with BioID or APEX2 approaches
Identify proximity partners in living cells
FRET/FLIM analysis:
Use secondary antibodies with appropriate fluorophores
Measure energy transfer between labeled proteins
Methodological considerations:
Optimize buffer conditions to preserve interactions
Use mild detergents (0.1% NP-40 or Digitonin)
Consider crosslinking to stabilize transient interactions
Include appropriate negative controls (isotype antibodies, unrelated proteins)
These approaches can reveal novel insights into OSL protein function within cellular networks and signaling pathways.
A methodological approach to Western blotting with OSL Antibody:
Sample preparation:
Extract proteins using buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitor cocktail
For plant tissues, include 1-2% polyvinylpyrrolidone (PVP) to remove interfering compounds
Determine protein concentration using Bradford or BCA assay
Gel electrophoresis:
Use 10-12% SDS-PAGE gels
Load 20-50 μg total protein per lane
Include molecular weight markers
Transfer conditions:
Transfer to PVDF membrane (0.45 μm) at 100V for 1 hour or 30V overnight at 4°C
Verify transfer with Ponceau S staining
Blocking:
Block with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature
Antibody incubation:
Dilute OSL Antibody 1:500 to 1:1000 in 5% BSA in TBST
Incubate overnight at 4°C with gentle rocking
Wash 3-5 times with TBST, 5 minutes each
Detection:
Use HRP-conjugated secondary antibody (1:5000-1:10000)
Develop using enhanced chemiluminescence
Optimize exposure time based on signal strength
Quantification:
Perform densitometric analysis
Normalize to loading controls
This protocol should be optimized for specific plant tissues and experimental conditions.
For effective immunoprecipitation of OSL protein:
Lysate preparation:
Use gentle lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, protease inhibitors)
For plant tissues, include PVP and PVPP to remove phenolic compounds
Clear lysate by centrifugation (14,000 × g, 15 minutes, 4°C)
Pre-clearing:
Pre-clear lysate with protein A/G beads (1 hour, 4°C)
Remove beads by centrifugation
Immunoprecipitation:
Use 2-5 μg OSL Antibody per 500 μg total protein
Incubate overnight at 4°C with rotation
Add pre-washed protein A/G beads
Incubate 2-4 hours at 4°C with rotation
Washing:
Wash 4-5 times with lysis buffer
Consider stringency gradient in washes
Elution:
Elute with SDS sample buffer (95°C, 5 minutes)
For native elution, use excess antigen peptide
Analysis:
Analyze by Western blot or mass spectrometry
Include input, unbound, and IP fractions
This methodology enables the study of OSL protein complexes and interacting partners under various experimental conditions.
Based on experimental design principles for antibody-based detection systems:
Plate coating optimization:
Test different coating buffers (carbonate pH 9.6, PBS pH 7.4)
Optimize coating concentration (1-10 μg/ml)
Determine optimal coating temperature and time
Blocking optimization:
Compare different blocking agents (BSA, casein, normal serum)
Test blocking time and temperature
Antibody dilution optimization:
Perform checkerboard titration of primary and secondary antibodies
Determine optimal dilution ranges
Incubation parameters:
Compare different incubation times and temperatures
Optimize washing steps (number, duration, buffer composition)
Substrate reaction:
Standard curve:
Prepare recombinant OSL protein standards
Determine optimal concentration range
Evaluate curve-fitting models
Validation:
Assess specificity, sensitivity, precision, and accuracy
Determine detection limits
Evaluate matrix effects
The optimization process should follow statistically valid experimental design as described in the literature, testing critical factors in factorial experiments to identify significant parameters and interactions .
When optimizing immunohistochemistry/immunofluorescence:
Fixation optimization:
Compare different fixatives (4% PFA, acetone, ethanol)
Test fixation times and temperatures
Evaluate fresh frozen vs. fixed tissue
Antigen retrieval methods:
Heat-induced epitope retrieval (citrate buffer pH 6.0, EDTA pH 9.0)
Enzymatic retrieval (proteinase K, trypsin)
Optimize retrieval time and temperature
Signal amplification:
Avidin-biotin complex (ABC) method
Tyramide signal amplification
Polymer-based detection systems
Background reduction:
Optimize blocking (3-5% normal serum, 1-3% BSA)
Include detergent in washing buffer (0.1-0.3% Triton X-100)
Pre-absorb antibodies if necessary
Block endogenous peroxidase/phosphatase activity
Antibody optimization:
Test multiple dilutions (1:50-1:500)
Optimize incubation time and temperature
Consider different detection systems
Controls:
Include positive and negative tissue controls
Secondary antibody-only controls
Peptide competition controls
Systematic documentation of these parameters allows for reliable protocol development and troubleshooting.
Proper normalization is essential for accurate data interpretation:
Western blot quantification:
Densitometric analysis using validated software
Normalize to housekeeping proteins (actin, tubulin, GAPDH)
Consider total protein normalization methods (Stain-Free, Ponceau S)
Use technical and biological replicates (n≥3)
Apply appropriate statistical tests
ELISA quantification:
Generate standard curves using purified recombinant protein
Perform spike-recovery experiments to account for matrix effects
Express results as absolute concentration or relative to control
Include quality control samples across plates
Immunohistochemistry quantification:
Assess percentage of positive cells
Measure staining intensity (H-score, Allred score)
Use digital image analysis for objective assessment
Normalize to reference samples on same slide
Reporting standards:
Clearly document normalization method
Report both raw and normalized data
Include measures of variability (standard deviation, standard error)
Report sample sizes and statistical significance
These approaches ensure rigorous quantification and comparison across experimental conditions.
Understanding potential artifacts is critical for accurate data interpretation:
False positive sources:
Cross-reactivity with related proteins
Non-specific binding to plant components
Insufficient blocking
Excessive antibody concentration
Endogenous enzyme activity in detection systems
Sample contamination
False negative sources:
Epitope masking due to protein-protein interactions
Post-translational modifications affecting antibody binding
Insufficient antigen retrieval
Protein degradation during sample preparation
Suboptimal antibody concentration
Incompatible buffers or detergents
Mitigation strategies:
Validate antibody specificity using multiple approaches
Include comprehensive positive and negative controls
Test multiple antibody concentrations
Use orthogonal detection methods for confirmation
Apply peptide competition assays
Researchers should systematically evaluate these potential artifacts when establishing new protocols or troubleshooting inconsistent results.
Rigorous validation is essential for reliable results:
Genetic validation:
Test in OSL knockout/knockdown systems
Compare wild-type vs. OSL-overexpressing samples
Use CRISPR/Cas9-edited plant lines when available
Biochemical validation:
Peptide competition assays
Detection of recombinant OSL protein
Immunoprecipitation followed by mass spectrometry
Testing multiple antibodies targeting different epitopes
Orthogonal validation:
Compare protein expression with mRNA levels
Use alternative detection methods (e.g., mass spectrometry)
Test in multiple plant systems or tissue types
Reporting standards:
Document complete antibody information (vendor, catalog number, lot)
Report all validation experiments performed
Follow established antibody validation guidelines
Include validation data with experimental results
These statistical approaches ensure rigor and reproducibility in OSL protein expression studies.